ArticleACS omega2026
Skin Barrier Modulation by Oleyl-Based Co-Formulants: Mechanistic Insights from Molecular Simulations.
Article in ACS omega, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Understanding and predicting dermal absorption is important for many applications including transdermal drug delivery, personal care product development, and chemical risk assessment. Real-world dermal exposures typically involve chemically complex formulations that contain not only the active ingredient but also coformulants such as solvents, thickeners, humectants and emulsifiers, which can significantly alter skin permeability and dermal absorption. In the case of personal care and pharmaceutical formulations, penetration enhancers are often added to improve delivery of active ingredients, however the interaction of these ingredients with the skin and how they modulate skin barrier function is poorly understood. In this work, we have used molecular dynamics simulations to investigate how a series of oleyl homologues with varying polyoxyethylene (POE) headgroups, partition into model stratum corneum lipid bilayers and alter their structural organization and barrier properties. These molecules are widely used as coformulants in the chemical and pharmaceutical industries. The simulations show that all of the compounds spontaneously partition into the bilayer within hundreds of nanoseconds. Once partitioned, they disrupt the interfacial hydrogen bonding network and lipid order, reducing the free energy barrier to water permeation across the bilayer. The extent of disruption correlates with POE headgroup length, with longer POE chains causing more pronounced disruption of the interface and enhanced permeability. These simulations provide the first atomistic insights into how methyl oleate and POE oleyl ethers affect skin barrier properties. Our findings highlight the critical role of coformulants in modulating dermal absorption and provide a molecular basis to guide formulation design and support robust safety assessment of dermal exposure.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.